Health Catalyst, Inc. (NASDAQ:HCAT) Receives $14.55 Average Target Price from Analysts

Shares of Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) have received an average rating of “Moderate Buy” from the nine ratings firms that are presently covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month […]

Related Keywords

United States ,Hong Kong ,Alger ,Algeria , ,Health Catalyst Company Profile ,Hedge Funds Weigh In On Health Catalyst ,Nasdaq ,Macquarie Group Ltd ,Hong Kong Ltd ,Securities Exchange Commission ,Analyst Recommendations For Health Catalyst ,Us Bancorp ,Health Catalyst Trading ,Canaccord Genuity Group ,Fairfield Bush ,Cantor Fitzgerald ,News Ratings For Health Catalyst Daily ,Health Catalyst Inc ,Health Catalyst ,Wealthplan Investment Management ,Get Free Report ,Exchange Commission ,Kong Ltd ,Plan Investment Management ,Get Free ,Health Catalyst Daily ,Nasdaq Hcat ,Thcat ,Medical ,Ratings ,Consensus ,